Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1997 1
2006 1
2007 1
2009 1
2010 1
2011 2
2012 2
2013 3
2014 3
2015 3
2016 1
2017 1
2018 1
2020 1
2021 4
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Management of Preinvasive Lesions.
Patrono MG, Corzo C, Iniesta M, Ramirez PT. Patrono MG, et al. Clin Obstet Gynecol. 2017 Dec;60(4):771-779. doi: 10.1097/GRF.0000000000000316. Clin Obstet Gynecol. 2017. PMID: 28957950 Review.
Serous tubal intraepithelial carcinoma is considered the precursor lesion of high-grade serous carcinoma, and found in both low-risk and high-risk populations. Isolated serous tubal intraepithelial carcinomas in patients with BRCA1/2 mutations are detected in 2% of …
Serous tubal intraepithelial carcinoma is considered the precursor lesion of high-grade serous carcinoma, and found in both lo …
Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a clinical practice guideline.
Auer RC, Sivajohanathan D, Biagi J, Conner J, Kennedy E, May T. Auer RC, et al. Curr Oncol. 2020 Jun;27(3):146-154. doi: 10.3747/co.27.6033. Epub 2020 Jun 1. Curr Oncol. 2020. PMID: 32669924 Free PMC article.
RESULTS: Recommendation 1a: For patients with newly diagnosed stage iii primary epithelial ovarian or fallopian tube carcinoma, or primary peritoneal carcinoma, hipec should be considered for those with at least stable disease after neoadjuvant …
RESULTS: Recommendation 1a: For patients with newly diagnosed stage iii primary epithelial ovarian or fallopian tube carcinoma …
Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II- IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review.
Hirte H, Poon R, Yao X, May T, Ethier JL, Petz L, Speakman J, Elit L. Hirte H, et al. Crit Rev Oncol Hematol. 2021 Jun;162:103324. doi: 10.1016/j.critrevonc.2021.103324. Epub 2021 Apr 20. Crit Rev Oncol Hematol. 2021. PMID: 33862245 Review.
BACKGROUND: To systematically review neoadjuvant and adjuvant therapy options for women with newly diagnosed stage II-IV ovarian cancer. METHODS: Phase III trials were searched using MEDLINE, EMBASE, and Cochrane Library. Maintenance therapies were excluded. RESULTS …
BACKGROUND: To systematically review neoadjuvant and adjuvant therapy options for women with newly diagnosed stage II-IV ovarian canc …
Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review.
Hirte H, Yao X, Ferguson SE, May T, Elit L. Hirte H, et al. Crit Rev Oncol Hematol. 2021 Jun;162:103336. doi: 10.1016/j.critrevonc.2021.103336. Epub 2021 Apr 16. Crit Rev Oncol Hematol. 2021. PMID: 33865996 Review.
BACKGROUNDS: To systematically review the effectiveness and harm of consolidation or maintenance therapy in patients with newly diagnosed stage II-IV EOC. METHODS: MEDLINE, EMBASE, PubMed, Cochrane Library, and PROSPERO databases, and four relevant conferences were systema …
BACKGROUNDS: To systematically review the effectiveness and harm of consolidation or maintenance therapy in patients with newly diagn …
Germline mutations in Black patients with ovarian, fallopian tube and primary peritoneal carcinomas.
Somasegar S, Weiss AS, Norquist BM, Khasnavis N, Radke M, Manhardt E, Pennil C, Pennington KP, Eckert MA, Chryplewicz A, Lengyel E, Swisher EM. Somasegar S, et al. Gynecol Oncol. 2021 Oct;163(1):130-133. doi: 10.1016/j.ygyno.2021.08.017. Epub 2021 Aug 24. Gynecol Oncol. 2021. PMID: 34452747
We aimed to describe the demographics and presence of germline mutations in Black individuals with ovarian, fallopian tube or peritoneal carcinoma at two large academic institutions. METHODS: Fifty-one Black patients with invasive epithelial ovarian, fallopian tube, …
We aimed to describe the demographics and presence of germline mutations in Black individuals with ovarian, fallopian tube or peritoneal …
Emerging therapeutics for primary peritoneal cancer.
Slomovitz BM, Worley MJ, Markman M, Coleman RL. Slomovitz BM, et al. Expert Opin Emerg Drugs. 2011 Mar;16(1):71-84. doi: 10.1517/14728214.2011.526600. Expert Opin Emerg Drugs. 2011. PMID: 21352070 Review.
INTRODUCTION: Primary peritoneal cancer describes a malignancy that originates from the peritoneal lining of the abdomen. ...Because of this, both standard of care treatment algorithms and contemporary drug development protocols nearly uniformly consid …
INTRODUCTION: Primary peritoneal cancer describes a malignancy that originates from the peritoneal lining of the abdome …
Brain metastases in epithelial ovarian and primary peritoneal carcinoma.
Ratner ES, Toy E, O'Malley DM, McAlpine J, Rutherford TJ, Azodi M, Higgins SA, Schwartz PE. Ratner ES, et al. Int J Gynecol Cancer. 2009 Jul;19(5):856-9. doi: 10.1111/IGC.0b013e3181a83301. Int J Gynecol Cancer. 2009. PMID: 19574773
OBJECTIVES: Central nervous system metastases are believed to be becoming more clinically evident as long-term survival for epithelial ovarian cancer (EOC) and primary peritoneal cancer (PPC) has improved. Our objective was to report our experience with managing bra …
OBJECTIVES: Central nervous system metastases are believed to be becoming more clinically evident as long-term survival for epithelial ovari …
Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR).
McCluggage WG, Judge MJ, Clarke BA, Davidson B, Gilks CB, Hollema H, Ledermann JA, Matias-Guiu X, Mikami Y, Stewart CJ, Vang R, Hirschowitz L; International Collaboration on Cancer Reporting. McCluggage WG, et al. Mod Pathol. 2015 Aug;28(8):1101-22. doi: 10.1038/modpathol.2015.77. Epub 2015 Jun 19. Mod Pathol. 2015. PMID: 26089092 Free article. Review.
We describe the development of a cancer data set by the ICCR expert panel for the reporting of primary ovarian, fallopian tube and peritoneal carcinoma and present the 'required' and 'recommended' elements to be included in the report with an explanatory comm …
We describe the development of a cancer data set by the ICCR expert panel for the reporting of primary ovarian, fallopian tube and …
Neoadjuvant and Adjuvant Systemic Therapy for Newly Diagnosed Stage II-IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma: A Practice Guideline.
Hirte H, Poon R, Yao X, May T, Ethier JL, Petz L, Speakman J, Elit L. Hirte H, et al. Curr Oncol. 2022 Jan 8;29(1):231-242. doi: 10.3390/curroncol29010022. Curr Oncol. 2022. PMID: 35049696 Free PMC article.
BACKGROUND: This study aims to provide guidance for the use of neoadjuvant and adjuvant systemic therapy in women with newly diagnosed stage II-IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma. ...For those with a high-risk profile …
BACKGROUND: This study aims to provide guidance for the use of neoadjuvant and adjuvant systemic therapy in women with newly diagnose …
25 results